Iodosan

Iodosan is a well-established product in the personal care sector, specifically designed for oral hygiene. The brand and product have roots in innovation aimed at improving dental health.

The product is currently produced by Haleon Medical Devices, a company that emerged from the separation of GlaxoSmithKline's (GSK) consumer healthcare division in 2022. GSK originally acquired the brand through its purchase of Block Drug in 2001, which laid the groundwork for the development of effective solutions for sensitive teeth.

Manufactured in Dungarvan, Ireland, this specific product is a part of Haleon’s commitment to quality oral care. The Waterford facility serves as a primary production hub, strategically located to cater to the European market. The packaging features Italian labeling and includes instructions for local recycling, ensuring compliance with regional distribution regulations. This detail highlights the brand's focus on sustainability as well as its tailored approach for different markets.